SIGNIFY: the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease
The SIGNIFY trial is testing the hypothesis that treatment with ivabradine reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure.
